Gainers
- ObsEva SA OBSV shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.
- Aeglea BioTherapeutics, Inc. AGLE shares rose 30.8% to $0.54 in pre-market trading. Aeglea BioTherapeutics, last week, reported a Q2 loss of $0.27 per share.
- CarLotz, Inc. LOTZ shares rose 30.6% to $0.7403 in pre-market trading after the company reported financial results and announced a merger agreement with Shift Technologies Inc.
- T2 Biosystems, Inc. TTOO rose 25.6% to $0.1520 in pre-market trading after declining around 7% on Tuesday.
- BARK, Inc. BARK rose 20.3% to $2.13 in pre-market trading following better-than-expected Q1 results.
- SilverSun Technologies, Inc. SSNT shares rose 17.4% to $4.32 in pre-market trading after jumping over 19% on Tuesday.
- The Trade Desk, Inc. TTD rose 17.3% to $63.90 in pre-market trading after the company reported better-than-expected Q2 sales results and issued Q3 sales guidance above estimates.
- Synalloy Corporation SYNL rose 15.2% to $15.30 in pre-market trading after reporting a sharp rise in quarterly earnings.
- Aethlon Medical, Inc. AEMD rose 14.5% to $1.50 in pre-market trading following strong Q1 earnings.
- Clarus Therapeutics Holdings, Inc. CRXT shares rose 13.5% to $0.3580 in pre-market trading.
- Ra Medical Systems, Inc. RMED rose 11.2% to $0.1870 in pre-market trading after declining 11% on Tuesday. Ra Medical recently announced it entered into agreements to raise $$6.2 million through previously issued warrants.
- NewAge, Inc. NBEV rose 10.3% to $0.29 in pre-market trading.
- Array Technologies, Inc. ARRY rose 9.6% to $20.04 in pre-market trading after the company reported better-than-expected Q2 adjusted EPS and sales results.
- Athersys, Inc. ATHX rose 6.4% to $0.2949 in pre-market trading after dropping around 8% on Tuesday.
- AMTD IDEA Group AMTD rose 5.1% to $2.48 in pre-market trading after dipping more than 20% on Tuesday.
- Twitter, Inc. TWTR rose 4.3% to $44.65 in pre-market trading after Elon Musk sold Tesla shares and tweets about importance of avoiding emergency stock sale in "unlikely" event of forced deal.
- Tesla, Inc. TSLA rose 2.5% to $871.21 in pre-market trading. Tesla CEO Elon Musk sold $6.85 billion worth of the electric-vehicle maker's shares, according to filings made with the U.S. Securities and Exchange Commission on Tuesday.
Don’t forget to check out our premarket coverage here .
Losers
- OptimizeRx Corporation OPRX shares fell 21.8% to $17.40 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
- BigBear.ai Holdings, Inc. BBAI shares fell 20.4% to $2.18 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
- PLBY Group, Inc. PLBY shares fell 16.5% to $5.82 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results.
- Roblox Corporation RBLX fell 14.4% to $40.52 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and announced bookings were 4% down year over year.
- Evotec SE EVO fell 12.4% to $12.35 in pre-market trading. Evotec Biologics and Alpine Immune Sciences expanded partnership for commercial process development of ALPN-303.
- Nextdoor Holdings, Inc. KIND fell 12.2% to $3.16 in pre-market trading after the company reported downbeat Q2 results and issued weak Q3 forecast.
- Immatics N.V. IMTX fell 11% to $11.06 in pre-market trading. Immatics, on Tuesday, reported Q2 sales of $17.9 million.
- Coinbase Global, Inc. COIN fell 7.8% to $80.87 in pre-market trading after the company reported a wider-than-expected loss for its second quarter and also shared an updated full year guidance.
- Vertex Energy, Inc. VTNR fell 7.6% to $7.21 in pre-market trading. HC Wainwright & Co. maintained Vertex Energy with a Buy and lowered the price target from $25 to $15. Vertex Energy shares dipped 44% on Tuesday after the company reported worse-than-expected Q2 EPS.
- AbCellera Biologics Inc. ABCL fell 7.3% to $10.29 in pre-market trading following downbeat Q2 sales.
- Alcon Inc. ALC shares fell 5.6% to $71.21 in pre-market trading after the company reported Q2 results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in